Skip to content
Clinical Trials – home
Centre Hospitalier Universitaire De Montpellier
Sponsor

Centre Hospitalier Universitaire De Montpellier

France 191 Avenue Du Doyen Gaston Giraud, 34295 Montpellier, France

About the sponsor

Rheumatoid arthritis research includes treatment strategies for persistent inflammatory disease, with interest in biologic sequencing and disease control. Systemic sclerosis is also a focus, including severe, treatment-resistant forms associated with skin fibrosis and immune-mediated tissue damage.

  • Rheumatoid arthritis
  • Systemic sclerosis
  • Autoimmune disease

Work in this area reflects a strong interest in immune modulation, refractory disease, and outcomes linked to inflammatory activity.

About Specializations

Centre Hospitalier Universitaire De Montpellier runs clinical trials in conditions such as Hepatocellular carcinoma, Neurodevelopmental disorder, Relapsing-remitting multiple sclerosis, Cholangiocarcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

20 clinical trials

Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Carbidopa
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dimethyl Fumarate
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Oxaliplatin
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azithromycin Dihydrate
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Anaesthesia

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Dexmedetomidine
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Midazolam
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Daridorexant
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Acetazolamide
  • Sponsor:Centre Hospitalier Universitaire De Montpellier
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Carboxymaltose
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.